Advantagene's mission is to apply biotechnology advancements to develop drugs that
provide better health, better cost and better quality of life for cancer patients
and their families.
Advantagene is focused on preventing the recurrence and progression of cancer. As
cancer inevitably escapes the current treatment options, its recurrence and progression
is the largest cause of patient morbidity and mortality. Continued progress in fighting
cancer will require novel therapeutic approaches that improve current care. Advantagene’s
cytotoxic immunotherapy has shown promise in this goal.